Model
Edge
Alnylam Pharmaceuticals, Inc.
0001446125
Filing type
4
Filing date
Nov 13, 2025
Updated
Nov 14, 2025 ยท 2:13 PM
Copy reference
Filing
4
Statement of Changes in Beneficial Ownership